APA (7th ed.) Citation

P, R., S, S., J, S., MA, L., H, S., S, C., . . . N, A. (2023). Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases. Oncoimmunology, 12(1), 2261264. https://doi.org/10.1080/2162402X.2023.2261264

Chicago Style (17th ed.) Citation

P, Reid, et al. "Safety and Effectiveness of Combination Versus Monotherapy with Immune Checkpoint Inhibitors in Patients with Preexisting Autoimmune Diseases." Oncoimmunology 12, no. 1 (2023): 2261264. https://doi.org/10.1080/2162402X.2023.2261264.

MLA (9th ed.) Citation

P, Reid, et al. "Safety and Effectiveness of Combination Versus Monotherapy with Immune Checkpoint Inhibitors in Patients with Preexisting Autoimmune Diseases." Oncoimmunology, vol. 12, no. 1, 2023, p. 2261264, https://doi.org/10.1080/2162402X.2023.2261264.